Scott R Burrows
Scott R Burrows
Verified email at qimr.edu.au
TitleCited byYear
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
PT Illing, JP Vivian, NL Dudek, L Kostenko, Z Chen, M Bharadwaj, ...
Nature 486 (7404), 554, 2012
4782012
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
R Khanna, SR Burrows, MG Kurilla, CA Jacob, IS Misko, TB Sculley, ...
Journal of Experimental Medicine 176 (1), 169-176, 1992
4131992
A structural basis for the selection of dominant αβ T cell receptors in antiviral immunity
L Kjer-Nielsen, CS Clements, AW Purcell, AG Brooks, JC Whisstock, ...
Immunity 18 (1), 53-64, 2003
3572003
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
R Khanna, S Bell, M Sherritt, A Galbraith, SR Burrows, L Rafter, B Clarke, ...
Proceedings of the National Academy of Sciences 96 (18), 10391-10396, 1999
3151999
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.
VP Argaet, CW Schmidt, SR Burrows, SL Silins, MG Kurilla, DL Doolan, ...
Journal of Experimental Medicine 180 (6), 2335-2340, 1994
2901994
An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
SR Burrows, R Khanna, JM Burrows, DJ Moss
Journal of Experimental Medicine 179 (4), 1155-1161, 1994
2851994
HLA-B27–restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class i peptide loading
CA Peh, SR Burrows, M Barnden, R Khanna, P Cresswell, DJ Moss, ...
Immunity 8 (5), 531-542, 1998
2771998
Immune regulation in Epstein-Barr virus-associated diseases.
R Khanna, SR Burrows, DJ Moss
Microbiol. Mol. Biol. Rev. 59 (3), 387-405, 1995
2671995
T cell receptor recognition of a'super-bulged'major histocompatibility complex class I–bound peptide
FE Tynan, SR Burrows, AM Buckle, CS Clements, NA Borg, JJ Miles, ...
Nature immunology 6 (11), 1114, 2005
2642005
Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases
R Khanna, SR Burrows
Annual Reviews in Microbiology 54 (1), 19-48, 2000
2362000
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and …
M Rowe, R Khanna, CA Jacob, V Argaet, A Kelly, S Powis, M Belich, ...
European journal of immunology 25 (5), 1374-1384, 1995
2211995
Cytotoxic T-cell clones discriminate between A-and B-type Epstein-Barr virus transformants
DJ Moss, IS Misko, SR Burrows, K Burman, R McCarthy, TB Sculley
Nature 331 (6158), 719, 1988
2081988
T cell allorecognition via molecular mimicry
WA Macdonald, Z Chen, S Gras, JK Archbold, FE Tynan, CS Clements, ...
Immunity 31 (6), 897-908, 2009
2072009
Identification of cytotoxic T cell epitopes within Epstein‐Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype‐restricted immune …
R Khanna, SR Burrows, J Nicholls, LM Poulsen
European journal of immunology 28 (2), 451-458, 1998
2041998
AT cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule
FE Tynan, HH Reid, L Kjer-Nielsen, JJ Miles, MCJ Wilce, L Kostenko, ...
Nature immunology 8 (3), 268, 2007
1982007
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
SR Burrows, TB Sculley, IS Misko, C Schmidt, DJ Moss
Journal of Experimental Medicine 171 (1), 345-349, 1990
1831990
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition
WA Macdonald, AW Purcell, NA Mifsud, LK Ely, DS Williams, L Chang, ...
Journal of Experimental Medicine 198 (5), 679-691, 2003
1812003
T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
SR Burrows, SL Silins, DJ Moss, R Khanna, IS Misko, VP Argaet
Journal of Experimental Medicine 182 (6), 1703-1715, 1995
1771995
Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design
SA Thomson, R Khanna, J Gardner, SR Burrows, B Coupar, DJ Moss, ...
Proceedings of the National Academy of Sciences 92 (13), 5845-5849, 1995
1691995
The CDR3 regions of an immunodominant T cell receptor dictate the'energetic landscape'of peptide-MHC recognition
NA Borg, LK Ely, T Beddoe, WA Macdonald, HH Reid, CS Clements, ...
Nature immunology 6 (2), 171, 2005
1682005
The system can't perform the operation now. Try again later.
Articles 1–20